Showing results (81-90 of 589) with videos related to

Sort By:
Pageof 59
BMC Medicine|February 7, 2016
Advances in immunotherapy for melanomaJason M Redman, Geoffrey T Gibney, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Molecular Pathways and Mechanisms of BRAF in Cancer TherapyPoulikos I Poulikakos, Ryan J Sullivan, Rona Yaeger
American Journal of Clinical Dermatology|September 28, 2018
Mechanisms of Resistance to Immune Checkpoint BlockadeDavid Liu, Russell W Jenkins, Ryan J Sullivan
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 13, 2022
Adoptive Cell Transfer and Vaccines in Melanoma: The Horizon Comes Into ViewAllison Betof-Warner, Ryan J Sullivan, Amod Sarnaik
Hematology/Oncology Clinics of North America|July 6, 2024
Targeted Therapy Innovations for MelanomaDahiana Amarillo, Keith T Flaherty, Ryan J Sullivan
Current Oncology Reports|June 8, 2024
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic SuccessMike Wang, Ryan J Sullivan, Meghan J Mooradian
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 4, 2009
Targeted therapy for Kaposi sarcomaRyan J Sullivan, Liron Pantanowitz, Bruce J Dezube
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 21, 2017
Indoor Tanning Dependence in Young Adult WomenDarren Mays, Michael B Atkins, Jaeil Ahn, et al.
Cancer|March 1, 2014
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitorsAllison Ackerman, Oliver Klein, David F McDermott, et al.
Melanoma Research|July 9, 2014
Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case reportSuthee Rapisuwon, Kellie Parks, Waddah Al-Refaie, et al.
Pageof 59